专利检索 ap:("SMITHKLINE BEECHAMLABORATOIRES PHARMACEUTIQUES" OR "Smithkline Beecham S.A." OR "SMITHKLINE BEECHAM CORPORATION") AND inv:"MENTION, Jacky Andre Gustave,SmithKline Beecham" 第 1 页

1.

发明公开
PHARMACEUTICAL FORMULATIONS COMPRISING AMOXOCYLLIN AND CLAVULANATE 失效
标题翻译：阿莫西林克拉维装有药剂

公开(公告)号：EP0975342A1

公开(公告)日：2000-02-02

申请号：EP98912303.9

申请日：1998-02-10

申请人： SMITHKLINE BEECHAMLABORATOIRES PHARMACEUTIQUES , Smithkline Beecham S.A. , SMITHKLINE BEECHAM CORPORATION

发明人： MENTION, Jacky Andre Gustave,SmithKline Beecham , SANROMA BORDALLO Jose Luis,SmithKline Beecham SA. , STORM, Kevin,SmithKline Beecham Pharmaceuticals

IPC分类号： A61K31/43 , A61K9/50 , A61K9/20

CPC分类号： A61K9/5084 , A61K9/0007 , A61K9/0095 , A61K9/2077 , A61K31/43 , A61K2300/00

摘要： Novel co-amoxiclav formulations are described, having reduced weight compared to existing formulations, as well as formulations comprising amoxycillin and potassium clavulanate in a ratio of 8:1 and formulations prepared from granulates of amoxycillin and granulates of amoxycillin and clavulanate.